{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:25:32Z","timestamp":1760984732342},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Based upon the acquainted loss of dopaminergic neurons in the substantia nigra in Parkinson\u2019s disease (PD), we hypothesised changes in magnetic resonance imaging signal intensities of the basal ganglia to be useful as an additional technical tool in the diagnostic work-up.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Region-of-interest analyses (substantia nigra and globus pallidus internus) of T2-weighted scans were performed in seventy subjects with PD, 170 age- and gender-matched controls and 38 patients with an atypical form of neurodegenerative Parkinsonian syndrome (N\u2009=\u200911 multisystem atrophy, N\u2009=\u200922 progressive supranuclear palsy, N\u2009=\u20095 corticobasal syndrome).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In patients with PD, significant changes in signal intensities within the substantia nigra were observed compared to controls at p\u2009&lt;\u20090.001. For the globus pallidus internus, signal alterations in PD and progressive supranuclear palsy were found to be significant (p\u2009&lt;\u20090.001) if compared to controls. Furthermore, signal changes of substantia nigra correlated with signal intensities of globus pallidus internus in the ipsilateral hemisphere in both groups. Sensitivity was 86% and specificity was 90% for the combined analysis of substantia nigra and globus pallidus internus in the complete patient sample versus controls.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Signal alterations of substantia nigra and globus pallidus internus in routine magnetic resonance imaging were useful to distinguish patients with PD from controls. In addition, signal changes in globus pallidus internus could be used to differentiate progressive supranuclear palsy patients from controls. These analyses have the potential to serve as an additional non-invasive technical tool to support the individual differential diagnosis of PD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2377-12-163","type":"journal-article","created":{"date-parts":[[2012,12,29]],"date-time":"2012-12-29T19:14:35Z","timestamp":1356808475000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Signal alterations of the basal ganglia in the differential diagnosis of Parkinson\u2019s disease: a retrospective case-controlled MRI data bank analysis"],"prefix":"10.1186","volume":"12","author":[{"given":"Sarah","family":"Jesse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Kassubek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Peter","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert C","family":"Ludolph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Unrath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,29]]},"reference":[{"key":"701_CR1","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1093\/brain\/113.6.1823","volume":"113","author":"JM Feamley","year":"1990","unstructured":"Feamley JM, Lees AJ: Striatonigral degeneration: a clinicopathological study. Brain. 1990, 113: 1823-1842. 10.1093\/brain\/113.6.1823.","journal-title":"Brain"},{"key":"701_CR2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Daniel SE, Kilford L, Lees AJ: Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992, 55: 181-184. 10.1136\/jnnp.55.3.181.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"701_CR3","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1001\/archneur.57.3.369","volume":"57","author":"J Jankovic","year":"2000","unstructured":"Jankovic J, Rajput A, McDermott M, Perl D: The evolution of diagnosis in early Parkinson Disease. Arch Neurol. 2000, 57: 369-372. 10.1001\/archneur.57.3.369.","journal-title":"Arch Neurol"},{"key":"701_CR4","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1136\/jnnp.2008.144501","volume":"79","author":"R Caslake","year":"2008","unstructured":"Caslake R, Moore JN, Gordon JC, Harris CE, Counsell C: Changes in diagnosis with follow-up in an incident cohort of patients with parkinsonism. J Neurol Neurosurg Psychiatry. 2008, 79: 1202-1207. 10.1136\/jnnp.2008.144501.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"701_CR5","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00415-011-5952-x","volume":"258","author":"J Winkler","year":"2011","unstructured":"Winkler J, Ehret R, B\u00fcttner T, Dillmann U, Fogel W, Sabolek M, Winkelmann J, Kassubek J: Parkinson\u2019s disease risk score: Moving to a premotor diagnosis. J Neurol. 2011, 258: 311-315.","journal-title":"J Neurol"},{"key":"701_CR6","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1159\/000314498","volume":"7","author":"IU Isaias","year":"2010","unstructured":"Isaias IU, Antonini A: Single-photon emission computed tomography in diagnosis and differential diagnosis of Parkinson\u2019s disease. Neurodegener Dis. 2010, 7: 319-329. 10.1159\/000314498.","journal-title":"Neurodegener Dis"},{"key":"701_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0074-7742(10)90007-X","volume":"90","author":"S Behnke","year":"2010","unstructured":"Behnke S, Schr\u00f6der U, Berg D: Transcranial sonography in the premotor diagnosis of Parkinson\u2019s disease. Int Rev Neurobiol. 2010, 90: 93-106.","journal-title":"Int Rev Neurobiol"},{"key":"701_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.nic.2009.08.016","volume":"20","author":"K Seppi","year":"2010","unstructured":"Seppi K, Poewe W: Brain magnetic resonance imaging techniques in the diagnosis of parkinsonian syndromes. Neuroimaging Clin N Am. 2010, 20: 29-55. 10.1016\/j.nic.2009.08.016.","journal-title":"Neuroimaging Clin N Am"},{"key":"701_CR9","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1136\/jnnp.2007.121525","volume":"78","author":"LL Chan","year":"2007","unstructured":"Chan LL, Rumpel H, Yap K, Lee E, Loo HV, Ho GL: Case control study of diffusion tensor imaging in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2007, 78: 1383-1386. 10.1136\/jnnp.2007.121525.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"701_CR10","doi-asserted-by":"publisher","first-page":"3423","DOI":"10.1093\/brain\/awq212","volume":"133","author":"P Peran","year":"2010","unstructured":"Peran P, Cherubini A, Assogna F, Piras F, Quattrocchi C, Peppe A, Celsis P, Rascol O, Demonet JF, Stefani A, Pierantozzi M, Pontieri F, Caltagirone C, Spalletta G, Sabatini U: Magnetic resonance imaging markers of Parkinson\u2019s disease nigrostriatal signature. Brain. 2010, 133: 3423-3433. 10.1093\/brain\/awq212.","journal-title":"Brain"},{"key":"701_CR11","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1212\/01.wnl.0000340982.01727.6e","volume":"72","author":"DE Vaillancourt","year":"2009","unstructured":"Vaillancourt DE, Spraker MB, Prodoehl J, Abraham I, Corcos DM, Zhou XJ: High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology. 2009, 72: 1378-1384. 10.1212\/01.wnl.0000340982.01727.6e.","journal-title":"Neurology"},{"key":"701_CR12","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/jnnp.2003.021873","volume":"75","author":"K Yoshikawa","year":"2004","unstructured":"Yoshikawa K, Nakata Y, Yamada K, Nakagawa M: Early pathological changes in the parkinsonian brain demonstrated by diffusion tensor MRI. J Neurol Neurosurg Psychiatry. 2004, 75: 481-484. 10.1136\/jnnp.2003.021873.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"701_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak H, Ghebremedhin E, R\u00fcb U, Bratzke H, Del Tredici K: Stages in the development of Parkinson\u2019s disease-related pathology. Cell Tissue Res. 2004, 318: 121-134. 10.1007\/s00441-004-0956-9.","journal-title":"Cell Tissue Res"},{"key":"701_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Kilford L, Lees AJ: Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992, 55: 181-184. 10.1136\/jnnp.55.3.181.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"701_CR15","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1212\/WNL.57.8.1497","volume":"57","author":"AJDS Hughes","year":"2001","unstructured":"Hughes AJDS, Lees AJ: Improved accuracy of clinical diagnosis of Lewy body Parkinson\u2019s disease. Neurology. 2001, 57: 1497-1499. 10.1212\/WNL.57.8.1497.","journal-title":"Neurology"},{"key":"701_CR16","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/BF02309628","volume":"8","author":"SLP Gilman","year":"1998","unstructured":"Gilman SLP, Quinn N, Albanese A, Ben-Shlomo Y, Fowler C, Kaufmann H, Klockgether T, Lang A, Lantos P, Litvan I, Mathias C, Oliver E, Robertson D, Schatz I, Wenning G: Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology. Clin Auton Res. 1998, 8: 359-362. 10.1007\/BF02309628.","journal-title":"Clin Auton Res"},{"key":"701_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/WNL.47.1.1","volume":"47","author":"IAY Litvan","year":"1996","unstructured":"Litvan IAY, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS: Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele\u2013Richardson\u2013Olszewski syndrome): report of the NINDSSPSP international workshop. Neurology. 1996, 47: 1-9. 10.1212\/WNL.47.1.1.","journal-title":"Neurology"},{"key":"701_CR18","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1093\/jnen\/61.11.935","volume":"61","author":"DWBC Dickson","year":"2002","unstructured":"Dickson DWBC, Chin SS, Duyckaerts C, Horoupian D, Ikeda K, Jellinger K, Lantos PL, Lippa CF, Mirra SS, Tabaton M, Vonsattel JP, Wakabayashi K, Litvan I: Office of rare diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol. 2002, 61: 935-946.","journal-title":"J Neuropathol Exp Neurol"},{"key":"701_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/0022-510X(93)90041-V","volume":"114","author":"P Scheltens","year":"1993","unstructured":"Scheltens P, Barkhof F, Leys D: A semiquantitative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci. 1993, 114: 7-12. 10.1016\/0022-510X(93)90041-V.","journal-title":"J Neurol Sci"},{"key":"701_CR20","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","volume":"1","author":"JM Bland","year":"1986","unstructured":"Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986, 1: 307-310.","journal-title":"Lancet"},{"key":"701_CR21","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1212\/WNL.56.9.1195","volume":"56","author":"MT Hu","year":"2001","unstructured":"Hu MT, White SJ, Herlihy AH, Chaudhuri KR, Hajnal JV, Brooks DJ: A comparison of (18)F-dopa PET and inversion recovery MRI in the diagnosis of Parkinson\u2019s disease. Neurology. 2001, 56: 1195-2000. 10.1212\/WNL.56.9.1195.","journal-title":"Neurology"},{"key":"701_CR22","first-page":"1747","volume":"23","author":"H Oikawa","year":"2002","unstructured":"Oikawa H, Sasaki M, Tamakawa Y, Ehara S, Tohyama K: The substantia nigra in Parkinson Disease: proton density\u2013weighted spin-echo and fast short inversion time inversion-recovery MR findings. Am J Neuroradiol. 2002, 23: 1747-1756.","journal-title":"Am J Neuroradiol"},{"key":"701_CR23","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1109\/TITB.2010.2091279","volume":"15","author":"C Loizou","year":"2011","unstructured":"Loizou C, Pattichis MS, Seimenis I, Pantziaris M, Pattichis CS: Multiscale amplitude-modulation frequency-modulation (AM-FM) texture analysis of multiple sclerosis in brain MRI images. IEEE Trans Inf Technol Biomed. 2011, 15: 119-129.","journal-title":"IEEE Trans Inf Technol Biomed"},{"key":"701_CR24","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1136\/jnnp.2010.214890","volume":"82","author":"Y Rolland","year":"2011","unstructured":"Rolland Y, V\u00e9rin M, Payan CA, Duchesne S, Kraft E, Hauser TK, Jarosz J, Deasy N, Defevbre L, Delmaire C, Dormont D, Ludolph AC, Bensimon G, Leigh PN: A new MRI rating scale for progressive supranuclear palsy and multiple system atrophy: validity and reliability. J Neurol Neurosurg Psychiatry. 2011, 82: 1025-1032. 10.1136\/jnnp.2010.214890.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"701_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s100720300036","volume":"24","author":"M Savoiardo","year":"2003","unstructured":"Savoiardo M: Differential diagnosis of Parkinson\u2019s disease and atypical parkinsonian disorders by magnetic resonance imaging. Neurol Sci. 2003, 24: 35-37. 10.1007\/s100720300036.","journal-title":"Neurol Sci"},{"key":"701_CR26","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00234-006-0165-1","volume":"49","author":"C Nilsson","year":"2007","unstructured":"Nilsson C, Markenroth Bloch K, Brockstedt S, L\u00e4tt J, Widner H, Larsson EM: Tracking the neurodegeneration of parkinsonian disorders-a pilot study. Neuroradiology. 2007, 49: 111-119. 10.1007\/s00234-006-0165-1.","journal-title":"Neuroradiology"},{"key":"701_CR27","volume-title":"Springer (Berlin Heidelberg)","author":"H Braak","year":"2009","unstructured":"Braak H, Del Tredici K: Neuroanatomy and pathology of sporadic Parkinson\u2019s Disease. Springer (Berlin Heidelberg). 2009, ISBN 9783540798491"},{"key":"701_CR28","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0079-6123(08)64021-2","volume":"117","author":"H Braak","year":"1998","unstructured":"Braak H, De Vos RA, Jansen ENH, Bratzke HJ, Braak E: Neuropathological hallmarks of Alzheimer\u2019s and Parkinson\u2019s diseases. Prog Brain Res. 1998, 117: 267-285.","journal-title":"Prog Brain Res"},{"key":"701_CR29","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, De Vos RA, Jansen Steur EN, Braak E: Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging. 2003, 24: 197-211. 10.1016\/S0197-4580(02)00065-9.","journal-title":"Neurobiol Aging"},{"key":"701_CR30","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","volume":"114","author":"JM Fearnley","year":"1991","unstructured":"Fearnley JM: Ageing and Parkinson\u2019s disease: substantia nigra regional selectivity. Brain. 1991, 114: 2283-2301. 10.1093\/brain\/114.5.2283.","journal-title":"Brain"},{"key":"701_CR31","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1046\/j.1440-1789.2001.00403.x","volume":"21","author":"H Takahashi","year":"2001","unstructured":"Takahashi H, Wakabayashi K: The cellular pathology of Parkinson\u2019s disease. Neuropathology. 2001, 21: 315-322. 10.1046\/j.1440-1789.2001.00403.x.","journal-title":"Neuropathology"},{"key":"701_CR32","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1002\/mds.23722","volume":"26","author":"ST Schwarz","year":"2011","unstructured":"Schwarz ST, Rittman T, Gontu V, Morgan PS, Bajaj N, Auer DP: T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson\u2019s disease. Mov Disord. 2011, 26: 1633-1638. 10.1002\/mds.23722.","journal-title":"Mov Disord"},{"key":"701_CR33","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/jmri.22752","volume":"35","author":"AK Lotfipour","year":"2012","unstructured":"Lotfipour AK, Wharton S, Schwarz ST, Gontu V, Sch\u00e4fer A, Peters AM, Bowtell RW, Auer DP, Gowland PA, Bajaj NP: High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson\u2019s disease. J Magn Reson Imaging. 2012, 35: 48-55. 10.1002\/jmri.22752.","journal-title":"J Magn Reson Imaging"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-12-163.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2377-12-163\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-12-163","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-12-163.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T21:18:14Z","timestamp":1630531094000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/1471-2377-12-163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["701"],"URL":"https:\/\/doi.org\/10.1186\/1471-2377-12-163","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"10 April 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"163"}}